Skip to Main Content

Paper Details

GLP-1 and nicotine combination therapy engages hypothalamic and mesolimbic pathways to reverse obesity.
1
2023
(POMC) neurons, GLP-1, GLP-1R, Glucagon-like peptide-1 receptor, dopamine, dopaminergic neurons, genetically, hypothalamic proopiomelanocortin, liraglutide, mice, nicotine, nicotinic receptor, obese, obesity, weight
Author NameAffiliation
Tune H PersNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
  • 1 - 1

Datasets

Release 1.2